Catalyst Pharmaceuticals Rings the Nasdaq Stock Market Closing Bell

Published
Feb 28, 2023 4:11PM EST

Catalyst Pharmaceuticals (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing and commercializing novel medicines for patients living with rare diseases, visits the Nasdaq MarketSite in Times Square. In honor of the occasion, Patrick J. McEnany, Chairman and CEO of Catalyst, rings the Closing Bell.

Transcripts

No transcript available

More in this Series

See all